Application of new enhanced medium in indirect antiglobulin test by gel method

The objective of this study was to explore the efficacy of a new enhanced medium in indirect antiglobulin test by optimized gel method. Anti-IgG+ C3d and anti-IgG antiglobulin gel cards, and samples from three blood group systems: Rh, Kidd and MNSs were used. The new enhanced medium was incubated at 37°C for 5 minutes, low ionic strength solution (LISS) for 15 minutes, saline solution for 30 minutes, respectively. The sensitivity and specificity of blood group antibodies were then compared. The results showed that the specificity and sensitivity of the new enhanced medium incubated for 5 minutes were consistent with those of LISS and saline solution for 15 minutes and 30 minutes, respectively. The results suggest that the new enhanced medium be able to accelerate the binding of erythrocyte antibodies with antigens, reduce incubation time and optimize the detection process of indirect antiglobulin test by gel method.     

2623名患者红细胞不规则抗体筛选结果分析*

目的:对红细胞抗体筛选阳性的标本进行红细胞不规则抗体特异性鉴定与分析,为临床安全输血提供帮助。方法:2011年8月至2018年12月天津市各医院送至本中心实验室检测的2623份血液标本,进行红细胞不规则抗体筛选和鉴定;采用低离子强度溶液-抗人球蛋白微柱凝胶卡方法和盐水直接离心方法进行抗体筛选和抗体鉴定。结果:共检出2744个红细胞抗体,其中2139个为同种抗体,509个为自身抗体,96份标本未能确定抗体特异性;在所检出的同种抗体中,Rh系统的抗体最常见,占比为54.7％(其中抗-E 26.2％,抗-c 8.7％,抗-C 7.7％,抗-e 6.9％,抗-D 4.9％),MNS系统、Lewis系统、Kidd系统、P系统、Duffy系统、Kell系统、Diego系统均有抗体检出。结论:在输血前检测中,为预防检出不规则抗体的情况出现,应提前备血,以免由此导致的延迟输血,影响治疗。     

基因工程双特异抗体研究进展

双特异抗体特别是双特异性单链抗体、亮氨酸接链双特异性抗体、双特异性单链抗体毒素等是近几年来发展起来的很有前途的监床诊疗生物制剂 ,本文对其基因构建、边接肽设计、表达产物及活性等方面的新进展作了重点论述。     

Bioxun微柱凝胶筛查红细胞不规则抗体的研究

目的:探讨Bioxun微柱凝胶法(Bioxun Micro-column Gel anti-globulin Test,BMGT)筛查红细胞不规则抗体的敏感性和特异性。方法:使用盐水介质法(Saline Media Test,SMT)、传统抗人球法(Traditional anti-Globulin Test,TGT)、达亚美凝胶法(DiamedMicro-column Gel Test,DMGT)和Bioxun微柱凝胶法分别检测红细胞不规则抗体,对方法学灵敏度和特异性进行观察比较。结果:Bioxun微柱凝胶法与达亚美凝胶法的结果无显著差异(P>0.05),二者的敏感度和特异性超过盐水介质法和传统抗人球法(P<0.05)。结论:Bioxun微柱凝胶法操作快捷,敏感度高,适宜在临床输血中推广应用。     

Blood groups in the species survival plan®, European endangered species program,and managed in situ populations of bonobo (Pan paniscus), common chimpanzee (Pan troglodytes), gorilla (Gorilla ssp.), and orangutan (Pongo pygmaeus ssp.)

Blood groups of humans and great apes have long been considered similar, although they are not interchangeable between species. In this study, human monoclonal antibody technology was used to assign human ABO blood groups to whole blood samples from great apes housed in North American and European zoos and in situ managed populations, as a practical means to assist blood transfusion situations for these species. From a subset of each of the species (bonobo, common chimpanzee, gorilla, and orangutans), DNA sequence analysis was performed to determine blood group genotype. Bonobo and common chimpanzee populations were predominantly group A, which concurred with historic literature and was confirmed by genotyping. In agreement with historic literature, a smaller number of the common chimpanzees sampled were group O, although this O blood group was more often present in wild‐origin animals as compared with zoo‐born animals. Gorilla blood groups were inconclusive by monoclonal antibody techniques, and genetic studies were inconsistent with any known human blood group. As the genus and, specifically, the Bornean species, orangutans were identified with all human blood groups, including O, which had not been reported previously. Following this study, it was concluded that blood groups of bonobo, common chimpanzees, and some orangutans can be reliably assessed by human monoclonal antibody technology. However, this technique was not reliable for gorilla or orangutans other than those with blood group A. Even in those species with reliable blood group detection, blood transfusion preparation must include cross‐matching to minimize adverse reactions for the patient. Zoo Biol 30:427–444, 2011. © 2010 Wiley‐Liss, Inc.     

ABO blood groups in Chilean and Peruvian mummies. II. Results of agglutination-inhibition technique

ABO blood groups of Peruvian and Chilean mummies were determined with the agglutination-inhibition method. In Peru all ABO blood groups were found in the period from 3000 B.C. to 1400 A.D.; from this period to 1650 only A and O were seen. In Chile no B or AB was noted either in pre-Columbian or Colonial mummies. This confirms the archeological concept that the Chilean Indian was culturally as well as genetically different from the Peruvian Indian. Further studies using other genetic markers are in order, as well as changing certain preconceived notions on blood groups of American Indians.     

基于新靶点的抗真菌药物研究进展

侵袭性真菌感染的发病率正逐年上升。现有抗真菌药物由于抗菌谱有限、副作用大等原因,致使临床应用受限。因此,基于新靶点的抗真菌药物成为治疗真菌感染的迫切需要。近年来,抗真菌药物研究取得较大进展。其中,抑制真菌细胞壁合成的药物（如E1210和D11?2040）、抑制蛋白激酶或蛋白磷酸酶信号通路的药物（如KP?372?1、17?AAG、Mycograb）、靶向真菌毒力因子的单克隆抗体（如C7、213 Bi?18B7、188 Re?18B7）、激活宿主免疫系统的疫苗[如PEV7和β?（ Man）3?Fba?TT]等,正引起人们的关注。     

ABO blood typing of human skeletal remains in Hungary

The author reports about the theoretical effects of his paleoserologic investigations on some historical population genetics problems. First he refers to the essence of the two modifications by the help of which the fluorescent antibody method can be made suitable for blood typing or archeological skeletal remains and determines his working units (sample, series, "population") used in the paleoserologic researches. The benefits of the projection of the ABO blood typing results on the map of the cemetaries are demonstrated. The distribution of the several phenotypes are collated to the character or richness of the grave goods and to the taxonomic features of the late individuals. The thorough examination of the serogenetic distances among the several samples of a given historical period may cast more light on the ethnic interrelations of the earlier populations living in the same geographic area. Following up the serogenetic changes of a population during subsequent historical periods, new ideas can be gained about the importance of the environmental, economic, and demographic factors shaping the serogenetic profile of the population.     

The incidence and features of serological ABO subgroups among one million blood donors in Beijing

This study aims to determine the incidence of serological ABO subgroups from a large-scale database, along with the features of blood samples with serological ABO discrepancies. The serological ABO results of one million individuals were randomly sampled from a blood donor database in Beijing between 2009 and 2010. All samples were diagnosed by serological reverse and forward ABO typing using an automatic analyzer. The proportions of the normal ABO types were 27.28%, 31.57%, 30.56%, and 10.16% for blood types A, B, O, and AB, respectively. In samples in which ABO discrepancies or obvious weak agglutinin were identified in the forward or reverse typing, further tests to analyze the ABO subgroup were conducted. The overall incidence of ABO subgroups was 0.047%, with 14 ABO subgroups observed: A2, A3, Ax, Am, Aint, Aend, B2, B3, Bx, Bm, Bel, B(A), cisAB, and AB^h. In conclusion, this study revealed the exact normal ABO and subgroup distributions in the general, healthy population of Beijing using samples from a blood donor database.     

应用改良流式法检测猕猴和食蟹猴体内血型抗体水平的分布情况

绝大部分灵长类动物存在与人类相似的ABO血型系统,该研究采用改良流式法(flow cytometry method,FCM)检测猕猴及食蟹猴血清中血型抗体水平的分布情况。以流式细胞术为基础,使用商品化人源红细胞为靶细胞,并通过加入特异性荧光标记的抗人IgM或IgG二抗,对收集的实验用猕猴及食蟹猴的血清样本进行检测,以人类健康受试者的血清样本为对照,比较两者血型抗体水平的差异。结果显示:预先用人O型浓缩红细胞吸附猴血清中所含种属间非特异性抗体后,FCM法能够准确检测其血型抗体水平及分型,并且发现猴血清中天然血型抗体的水平明显低于健康人(P<0.05)。由此得出:通过预处理清除非特异性抗体的干扰后,FCM法同样适用于灵长类动物血清中血型抗体的检测,也为构建灵长类动物模拟人ABO血型不合器官移植模型提供了技术保障和实验数据。     

血型检测用反向定型试剂的研制

将正常的红细胞在特定条件下用甲醛处理,使红细胞膜固定但不影响膜表面糖蛋白血型抗原的活性。采用与正向定型相同的平板凝集试验方法,４０６０份血样正向和反向定型结果完全一致。经稳定性观察９０天,处理后的红细胞与相应抗体的凝集性能未见明显改变。实验结果表明本文介绍的红细胞试剂可用于ＡＢＯ血型鉴定的反向定型试验。     

性染色体微卫星标记在亲缘鉴定中的应用

性染色体短串联重复序列(short tandem repeat,STR),又称微卫星DNA(micro satellite DNA)作为一种特殊的遗传标记在法医学个体识别及亲缘鉴定中发挥着重要的作用。该文对亲子鉴定概念、原理和方法等基础知识以及性染色体STR的研究历史、特点以及局限性等进行综述,为性染色体STR在法医学、遗传学等方面的推广应用提供参考。     

血液因素对龈下菌斑BANA试验结果的影响

目的检测血液因素对慢性牙周炎龈下菌斑BANA试验敏感性、稳定性的影响。方法将不同血液成分及混有健康人血的牙龈卟咻菌菌液分别进行BANA试验。结果各检测稀释滴度的全血、冻融全血、血浆样本BANA试验反应均为阴性;当全血各稀释梯度中牙龈卟啉菌菌量大于10^5时反映结果呈现为BANA试验阳性,胰蛋白酶样酶A600nm值均大于0．20。结论BANA试验的敏感度并不受血液成分混入的影响而降低,证实试验具有较好的稳定性。     

Recent progress in brassinosteroid research

The progress of investigations in recent years of the occurrence, analysis, structure/activity relationships, physiology, role in stress responses, and applications of brassinosteroids is reviewed. Their inclusion in the category of plant hormones is now widely accepted, and much more research into the effects of brassinosteroids can be expected in future.     

建立膜抗原荧光抗体试验评价北京株冻干水痘疫苗免疫效果

为了建立用于水痘疫苗接种后血清中特异性抗体检测的膜抗原荧光抗体(FAMA)法,并对接种水痘疫苗后儿童血清中水痘特异性抗体进行检测,评价北京株水痘疫苗的免疫效果。以水痘带状疱疹病毒(VZV)感染细胞作为抗原制备成固定抗原玻片,以异硫氰酸荧光素(FITC)标记的羊抗人IgG作为二抗建立FAMA法,并对该法的敏感性、特异性进行验证。运用此法对不同剂量北京株水痘疫苗接种后儿童血清中特异性抗体进行检测,分析儿童血清中水痘特异性抗体水平以及免后抗体阳转率,并与Oka株水痘疫苗进行比较。结果显示,FAMA法敏感性可达0.0196IU/ml,特异性好。应用此法检测300名观察者免前免后双份血清样本中抗VZVIgG,易感者中北京株水痘疫苗原苗(39810PFU/0.5ml)、2000PFU/0.5ml、500PFU/0.5ml接种组儿童血清免后抗体阳转率分别为100%、98.77%、85.42%,抗体几何平均滴度(GMT)分别为36.4、34.3、18.6,原苗与2000PFU间的抗体阳转率和GMT均无显著性差异(P>0.05),但原苗与500PFU、2000PFU与500PFU间的抗体阳转率和GMT均有显著性差异(P<0.05)。对照国产、进口Oka株水痘疫苗接种后抗体阳转率分别为95.35%、96.97%,抗体GMT分别为13.3、16.0,不同剂量北京株疫苗抗体阳转率与国产、进口Oka株疫苗相比,差别无显著性(P>0.05),但北京株疫苗原?     

The relationship of Helicobacter pylori positivity with age, sex, and ABO/Rhesus blood groups in patients with gastrointestinal complaints in Turkey

BACKGROUND: To determine the magnitude of Helicobacter pylori infection in patients with gastrointestinal complaints in Turkey. METHODS: We studied 1680 patients with variable gastrointestinal complaints. The H. pylori infection status was determined using C-14 urea breath test (UBT). Overall, 1567 patients (548 male, 1019 female; age range 4-80 years, mean 29.37 +/- 17.30 years) were included in this study. The relationship between H. pylori positivity and age, sex, sociodemographic characteristic, blood groups, and gastrointestinal diagnosis was determined. RESULTS: H. pylori positivity was found to be 68%. The difference in positivity rates between age groups 4-9 years and other groups was statistically significant (p = .001). H. pylori positivity was 67.7% in males and 68.2% in females (p = .865). H. pylori positivity was 72.1, 65.1, 70, and 68.4% in blood groups A, B, AB, and O (p = .703), and 68.9% and 76.3% in Rh (+) and Rh (-) blood subgroups, respectively (p = .292). There was no statistically significant difference between H. pylori positivity and gastrointestinal diagnosis (p = .980). There was significant association between increased number of household members and low socioeconomic status, and H. pylori positivity (p < .001). Living in rural and suburban area was significantly associated with H. pylori positivity compared with living in urban. CONCLUSIONS: H. pylori infection positivity rate was 68% in symptomatic subjects in Turkey and the positivity rate was significantly lower at age 4-9 years than the other age groups. It was not related to gender, ABO, and Rh blood groups and gastrointestinal diagnosis. Low socioeconomic conditions and living in rural and suburban area were significantly associated with H. pylori positivity.     

宏基因组学技术的研究与挑战

宏基因组学研究作为研究微生物种群生态分布、群体遗传特征和基因相互作用的新兴学科领域,在很大程度上促进了环境微生物资源,特别是未培养微生物资源的开发利用,在土壤、海洋、人体医学、药物等各个领域的应用中取得了突破性的进展,为发现新的生物活性物质提供了新的有效途径。就宏基因组学研究进展进行综述,并重点介绍了宏基因组学研究中的机遇及挑战。     

The role of ABO blood groups and secretor status in host defences

Abstract Epidemiological studies on the associations between ABO blood group antigens, secretor status and susceptibility to infectious agents are summarized. Evidence for association of non-secretion with some autoimmune diseases for which infectious aetiologies have been proposed is also given. Several hypothesis are proposed to explain the host-parasite interactions underlying the epidemiological observations, and evidence to support or refute them is presented.     

Prevalence of antibodies against Simkania negevensis in a healthy Japanese population determined by the microimmunofluorescence test

Simkania negevensis has been associated with bronchiolitis in infants and community-acquired pneumonia in adults. Reports of exposure to this microorganism are only available from Israel, North America and Western Europe. Currently, no standard method for diagnosis of S. negevensis infection has been established nor have prevalence rates been shown in Japan. For the first time we demonstrated the ability of the microimmunofluorescence (MIF) test to detect S. negevensis-specific immunoglobulin G and exposure to S. negevensis in Japan. The positive rate in healthy volunteers was 4.3% (25/588), with rates increasing with age. Results indicate the usefulness of the MIF test as a serological method for detecting S. negevensis-specific antibodies. A standard serological test for infection with S. negevensis is needed.